LongeVC managing partner Garri Zmudze participated in the Longevity Investors Conference in Gstaad, Switzerland, from September 22–25, 2025. The invitation-only gathering brought together investors, scientists, and entrepreneurs to discuss the evolving landscape of longevity investment.
During the conference, Garri spoke about the challenges of backing biotech ventures across European markets, emphasizing that strategic patience and cross-border cooperation are now essential for success in the sector. The event featured discussions on AI-driven discovery, women's healthspan, and the shift toward evidence-based, translational approaches in the field of medicine.
Read more in the event recap by Eleanor Garth for Longevity.Technology here.
During the conference, Garri spoke about the challenges of backing biotech ventures across European markets, emphasizing that strategic patience and cross-border cooperation are now essential for success in the sector. The event featured discussions on AI-driven discovery, women's healthspan, and the shift toward evidence-based, translational approaches in the field of medicine.
Read more in the event recap by Eleanor Garth for Longevity.Technology here.